biotechnology

(redirected from Bio-technology)
Also found in: Dictionary, Medical, Financial, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for biotechnology

the branch of molecular biology that studies the use of microorganisms to perform specific industrial processes

the branch of engineering science in which biological science is used to study the relation between workers and their environments

References in periodicals archive ?
Under the terms of the agreement, Aida Pharmaceuticals will purchase an additional 45% of the outstanding shares of Shanghai Qiaer Bio-Technology for $495,650.
The Complaint alleges that Bio-Technology, a company that researches, develops, manufactures and markets bio-pharmaceutical products, and certain of its officers and directors issued materially false and misleading statements concerning Bio-Technology's earnings and revenue.
The Complaint charges Bio-Technology and certain of its executive officers with violations of federal securities laws.
NEW YORK -- Xethanol Corporation (OTCBB:XTHN), a leading bio-technology integration and ethanol production company, today announced that it officially reopened its BioFuels ethanol facility in Blairstown, Iowa, last week.
MINNEAPOLIS, July 30 /PRNewswire/ -- The boards of Techne Corporation (NASDAQ-NMS: TECH) and British Bio-technology Group plc (BBG) announce that the sale of British Bio-technology Products Limited (BBP) to Techne was completed today.
MINNEAPOLIS, June 28 /PRNewswire/ -- The boards of Techne Corporation (NASDAQ-NMS: TECH) (Techne) and British Bio-technology Group plc (BBG) announce that terms have been agreed in principle for the sale of British Bio-technology Products Limited (BBP) to Techne.
except in Israel, where it is owned by Bio-Technology General (Israel) Ltd.
TO HUMAN GROWTH HORMONE FROM SMITHKLINE BEECHAM NEW YORK, July 17 /PRNewswire/ -- Bio-Technology General Corp.
PHILADELPHIA, April 30 /PRNewswire/ -- British Bio-technology Group plc and SmithKline Beecham (NYSE: SBH) announced that they have signed an agreement for the collaborative research and commercialization of a class of compounds which may be useful as new treatments for arthritis and cancer.